Navigation Links
Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO

.com.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS (http://www.idispharma.com) on a program whereby both Ganite(R) and Genasense(R) are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward- looking statements include, without limitation, statements about:

    -- the Company's ability to obtain necessary regulatory approval for

       Genasense(R) from the U.S. Food and Drug Administration ("FDA") or

       European Medicines Agency ("EMEA");

    -- the safety and efficacy of the Company's products or product

       candidates;

    -- the Company's assessment of its clinical trials;

    -- the commencement and completion of clinical trials;

    -- the Company's ability to develop, manufacture, license and sell its

     
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/5/2015)...  Trovagene, Inc. (NASDAQ:  TROV), a developer of ... for the three months ended March 31, 2015. ... presented favorable clinical results at ASCO GI, AACR, ... Precision Cancer Monitoring platform,s ability to detect and ... cancers," said Antonius Schuh, Ph.D., chief executive officer ...
(Date:5/5/2015)... NEW YORK , May 5, 2015  IBM Watson ... collaborating with Epic and Mayo Clinic ... of Watson to Electronic Health Records (EHRs). ... benefit from more rapid and thorough analysis of the medical ... Epic has more than 350 customers – some ...
(Date:5/5/2015)... -- The preclinical contract research organization Absorption Systems , ... safety testing of medical devices, announces that Dr. ... at this week,s annual meeting of The Association for ... Denver, CO. The title of Dr. Gum,s ... Bio-Absorbable Carboxymethyl Hyaluronic Acid (CMHA) Polymer in a Rabbit ...
Breaking Medicine Technology:Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3
(Date:5/6/2015)... Hope For The Warriors® and American Legion Post ... New York Athletic Club on April 21, 2015. All ... a national nonprofit dedicated to restoring a sense of ... our service members and our military families. , Casino ... nationwide military families. The Barry Fixler Foundation/Semper Cool (fixlerfoundation.org) ...
(Date:5/6/2015)... May 06, 2015 The American Water ... period for its prestigious Integrated Water Resources Management (IWRM) ... approach to water resources projects. , An IWRM approach to ... establishment in 1964. In 2014, 12 projects were nominated for ... magazine features not only the 2014 AWRA IWRM Award winner ...
(Date:5/6/2015)... Boston, MA (PRWEB) May 06, 2015 Most ... years of long-term nursing or other care after age 65. ... beyond are saving for it or even talking about it, ... By not planning, people risk two problems. One is losing ... off to their families," says Dr. David Grabowski, a professor ...
(Date:5/6/2015)... Qualidigm , the national ... healthcare executive Ann Olson, RN, BSN, as a ... Qualidigm’s growing home healthcare services and develop strategic ... quality, safety, and cost-effectiveness of healthcare through transformational ... HealthCare of North Haven, Inc., a full-service home ...
(Date:5/6/2015)... NY (PRWEB) May 06, 2015 ... long-standing organization dedicated to activating and celebrating public ... Champion organization, Highmark Health, as an Outstanding Employee ... with the Jefferson Awards Foundation, are dedicated to ... For nearly a decade, Highmark Health has recognized ...
Breaking Medicine News(10 mins):Health News:4th Annual Casino Night Draws Support for Military Families in New York City Region 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4
... it may be better than standard oxygen therapy, study suggests ... that a mechanical ventilator can ease suffering and help lung ... A large percentage of these patients didn,t want to have ... wear an oxygen mask. But those who were willing to ...
... in Fight Against Tobacco Recognized Nationally-, WASHINGTON, May ... the Central Regional Youth Advocate of the Year,by the ... fight,against tobacco. Michelle is being honored at a gala ... national winner, international grant winner,three other regional winners and ...
... is Possible!, DETROIT, Mich., May 19 Patrick Hendry ... of bipolar disorder.,He spent seven years in and out of ... went so far as trying,electro-convulsive therapy, similar to shock therapy., ... my life. You feel,hopeless and lost," said Hendry. "It,s difficult ...
... WASHINGTON, May 20 Auriel Rolle-Polk, 17, of,Tallahassee, FL ... the,Year by the Campaign for Tobacco-Free Kids for her ... at a gala in the nation,s capital,on May 20 ... regional winners and a group winner., Auriel, a ...
... 20 Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ... its fourth quarter and fiscal year 2008 ended ... Thursday May 29, 2008., Detroit-based Caraco Pharmaceutical ... private-label,pharmaceuticals to the nation,s largest wholesalers, distributors,drugstore chains ...
... Ischemic injury to the bowel is a well known disease ... findings. A sudden drop in the colonic blood supply is ... of macrovascular mesenteric vein rarely causes ischemia of the bowel. ... by obstruction of the mesenteric and splenic veins. , ...
Cached Medicine News:Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 2Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 3Health News:Campaign for Tobacco-Free Kids Honors Michelle Mays of Rhinelander, WI As Youth Advocate of the Year 2Health News:Man who Lost Everything Comes to Detroit to Spread Message of Hope 2Health News:Campaign for Tobacco-Free Kids Honors Auriel Rolle-Polk of Tallahassee, FL As Youth Advocate of the Year 2Health News:Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008 2
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... We offer a complete line ... laboratorians state-of-the-art monoclonal and monoclonal/polyclonal ... detection of enteric pathogens in ... products for Clostridium difficile, Entamoeba ...
... The C. Difficile Tox A/B II test ... Diagnostics's exclusive Fecal-Quik-Prep device which greatly reduces ... specimens for Tox A/B II testing. The ... device that greatly reduces the amount of ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
Medicine Products: